genetic variants affecting the reverse transport of DA might influence the risk of common, sporadic forms of autism remains open. It is now widely accepted that rare genetic variants could play an important role in susceptibility to common diseases. In light of Cartier et al.'s results, major resequencing efforts of the SLC6A3 and STX1A genes should be undertaken in large cohorts of individuals with autism, with significant insights into disease biology likely from these results.
Another interesting implication of the work by Cartier and colleagues lies in unraveling the therapeutic potential of DA reverse transport in autism. Starting from the observation that rare autism-causing variants are associated with inhibition of reverse transport of DA, it could be hypothesized that psychostimulants may serve as a potential therapeutic aid in autism. Notably, not only have psychostimulants been suggested to be effective for ADHD-like symptoms in autism spectrum disorder individuals, but the prevalence rates of their use in autism are also strikingly increasing (Dalsgaard et al., 2013) . It should be noted, however, that AMPH (which is known to cause reverse transport of DA) has been also shown to elicit autism-like symptoms including stereotyped behaviors and social impairments in animal models (Moy et al., 2013 (Moy et al., , 2014 . Based on this evidence, the conclusion that increasing the reverse transport of DA could represent a novel therapeutic target in autism per se (and not for the ADHD-like symptoms in autism) is probably too premature. However, it is becoming increasingly clear that the reverse transport of DA could be one of the key mechanisms involved in the fine-tuning of DA levels in the synapse. In this scenario, the work by Cartier and colleagues is relevant in unraveling how disruption of such synaptic dopaminergic fine-tuning could ultimately result in autism.
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